Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egeberg

Showing results (231-240 of 332) with videos related to

Pageof 34
Sort By:
Dermatology and Therapy|October 15, 2024
Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with BaricitinibBrittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, et al.
Frontiers in Medicine|February 13, 2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
Frontiers in Medicine|March 28, 2023
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
JAAD International|April 19, 2024
Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativaNikolaj Holgersen, Valdemar Wendelboe Nielsen, Nana Aviaaja Lippert Rosenø, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort studyAmalie Thorsti Møller Rønnstad, Mia-Louise Nielsen, Christoph Schlapbach, et al.
Acta Dermato-Venereologica|December 15, 2020
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Dermatology and Therapy|September 10, 2024
Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc AnalysisJennifer Fu, Alexander Egeberg, Susan Holmes, et al.
Dermatology and Therapy|June 21, 2024
Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with BaricitinibBrittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, et al.
Journal of the American Academy of Dermatology|August 9, 2016
Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasisJashin J Wu, Bruce E Strober, Peter R Hansen, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 13, 2020
Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobiaTrine Gerner, Jeanette Halskou Haugaard, Christian Vestergaard, et al.
Pageof 34

Showing results (231-240 of 332) with videos related to

Sort By:
Pageof 34
Dermatology and Therapy|October 15, 2024
Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with BaricitinibBrittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, et al.
Frontiers in Medicine|February 13, 2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
Frontiers in Medicine|March 28, 2023
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.
JAAD International|April 19, 2024
Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativaNikolaj Holgersen, Valdemar Wendelboe Nielsen, Nana Aviaaja Lippert Rosenø, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort studyAmalie Thorsti Møller Rønnstad, Mia-Louise Nielsen, Christoph Schlapbach, et al.
Acta Dermato-Venereologica|December 15, 2020
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Dermatology and Therapy|September 10, 2024
Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc AnalysisJennifer Fu, Alexander Egeberg, Susan Holmes, et al.
Dermatology and Therapy|June 21, 2024
Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with BaricitinibBrittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, et al.
Journal of the American Academy of Dermatology|August 9, 2016
Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasisJashin J Wu, Bruce E Strober, Peter R Hansen, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 13, 2020
Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobiaTrine Gerner, Jeanette Halskou Haugaard, Christian Vestergaard, et al.
Pageof 34